Beyond Alzheimer’s disease, APOE ε4 is also linked to mild cognitive impairment (MCI) (4, 5), typical aging (6, 7), and other neurodegenerative conditions like Lewy body dementia (LBD) (8) and vascular dementia (VD) (9). Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.